Hormonal Treatment and Depression

Past research has demonstrated a link between traditional prostate cancer hormone therapy (HT) and the risk of depression among prostate cancer patients.

A retrospective clinical trial investigated whether second-generation antiandrogens (AAs) are also associated with increased risk of depression.

Three treatments were compared during the study: no HT, traditional HT, and second-generation AA.

Results indicate that patients receiving a second-generation AA had an increased risk of depression compared with traditional HT alone or no HT.

These findings emphasize the need for emotional distress monitoring and the implantation of focused interventions to alleviate symptoms among these patients.

For more info:

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2787430.

This content is provided for your general education and information only. It does not necessarily reflect Belong’s views and opinions. Belong does not endorse or support any specific product, service or treatment.

More Articles

Practical Ways to Manage Chemo Brain

Chemo brain, or cognitive difficulties caused by cancer treatment, can make daily tasks challenging. While…

Seeing Double? Let’s Dive into MS and Diplopia

Diplopia, or double vision, occurs when your brain receives mismatched signals from your eyes, leading…

Supplements and Cancer Treatments

Weighing the Pros and Cons. Many cancer patients turn to dietary supplements to support their…

Managing Depression with MS

Living with multiple sclerosis (MS) is more than just a physical challenge—it can also take…

Chemo and Back Pain – Understanding the Connection

Many cancer patients experience back pain during chemotherapy, a side effect that multiple factors can…

Vitamin D Reduces MS Activity

A recent study, the D-Lay MS trial, found that high-dose vitamin D3 significantly reduced disease…
Skip to content